| __timestamp | Arrowhead Pharmaceuticals, Inc. | Vertex Pharmaceuticals Incorporated |
|---|---|---|
| Wednesday, January 1, 2014 | 175000 | 580415000 |
| Thursday, January 1, 2015 | 382000 | 1032336000 |
| Friday, January 1, 2016 | 158333 | 1702177000 |
| Sunday, January 1, 2017 | 31407709 | 2488652000 |
| Monday, January 1, 2018 | 16142321 | 3047597000 |
| Tuesday, January 1, 2019 | 168795577 | 4162821000 |
| Wednesday, January 1, 2020 | 87992066 | 6205683000 |
| Friday, January 1, 2021 | 138287000 | 7574400000 |
| Saturday, January 1, 2022 | 243231000 | 8930700000 |
| Sunday, January 1, 2023 | 240735000 | 9869200000 |
| Monday, January 1, 2024 | 3551000 | 11020100000 |
Unlocking the unknown
In the competitive landscape of biotechnology, Vertex Pharmaceuticals Incorporated and Arrowhead Pharmaceuticals, Inc. have been vying for dominance. Over the past decade, Vertex has consistently outpaced Arrowhead in annual revenue, showcasing a robust growth trajectory. From 2014 to 2023, Vertex's revenue surged by over 1,600%, peaking at nearly $9.9 billion in 2023. In contrast, Arrowhead's revenue, while growing, remains a fraction of Vertex's, with a notable increase of approximately 137% over the same period, reaching around $240 million in 2023.
Vertex's impressive revenue growth can be attributed to its innovative treatments and strategic market positioning. Meanwhile, Arrowhead, though smaller in scale, has shown potential with its focus on RNA interference therapies. As we look to the future, the question remains: Can Arrowhead close the gap, or will Vertex continue to lead the charge?
Vertex Pharmaceuticals Incorporated vs Alnylam Pharmaceuticals, Inc.: Annual Revenue Growth Compared
Who Generates More Revenue? Vertex Pharmaceuticals Incorporated or Corcept Therapeutics Incorporated
Breaking Down Revenue Trends: Vertex Pharmaceuticals Incorporated vs Perrigo Company plc
Who Generates More Revenue? Vertex Pharmaceuticals Incorporated or Veracyte, Inc.
Vertex Pharmaceuticals Incorporated vs Celldex Therapeutics, Inc.: Examining Key Revenue Metrics
Comparing Revenue Performance: Regeneron Pharmaceuticals, Inc. or Arrowhead Pharmaceuticals, Inc.?
Breaking Down Revenue Trends: Viatris Inc. vs Arrowhead Pharmaceuticals, Inc.
Annual Revenue Comparison: Lantheus Holdings, Inc. vs Arrowhead Pharmaceuticals, Inc.
Revenue Insights: Grifols, S.A. and Arrowhead Pharmaceuticals, Inc. Performance Compared
Who Generates More Revenue? Veracyte, Inc. or Arrowhead Pharmaceuticals, Inc.
Arrowhead Pharmaceuticals, Inc. vs BioCryst Pharmaceuticals, Inc.: Examining Key Revenue Metrics
Revenue Showdown: Arrowhead Pharmaceuticals, Inc. vs Evotec SE